SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Interim Trading Update

24 Jul 2018 07:00

RNS Number : 5118V
Ebiquity PLC
24 July 2018
 

Ebiquity Plc

("the Company")

 

 

Interim Trading Update

 

 

Ebiquity plc, a leading independent marketing and media consultancy, today announces its interim update for the 6 months ended 30 June 2018 ("the period").

 

Whilst first half revenues from the Media (formerly Media Value Measurement) segment and Analytics & Tech (formerly Marketing Performance Optimization) segment grew 7% over the prior year on a like-for-like ("LFL") basis, uncertainty arising from the UK Competition and Markets Authority ("CMA") investigation into the planned disposal of the Intel segment to Nielsen, announced in February 2018, has impacted Intel sales with H1 2018 LFL revenues down 9% versus 2017.

 

We have accelerated the phasing of investment in the growing Media and Analytics & Tech segments (representing c78% of the business) in the first half on the back of strong new business pipelines. As a result, we already have visibility into faster (double digit) revenue growth within these segments in H2 2018. Although this accelerated investment will impact H1 operating profit, performance in these segments for the full year is anticipated to meet existing expectations.

 

In the Intel segment (representing c22% of the business), the CMA Phase 2 process is formally due to complete no later than December 2018, we therefore anticipate that uncertainty will continue to impact revenues and profits in the second half of the year.

 

Overall, the impact of the performance of the Intel segment will not be entirely offset by the strong performance from Media and Analytics & Tech and consequently the Board currently anticipates profits for the year to be less than full-year market expectations.

 

The Company will release its interim report for the 6 months ended 30 June 2018 on 25 September 2018.

24 July 2018

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Andrew Noble (CFO)

 

020 7650 9600

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

020 7457 2020

 

Numis Securities Limited

Nick Westlake (NOMAD)

Toby Adcock (Corporate Broker)

 

020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLFFLLDTIVFIT
Date   Source Headline
30th May 20193:20 pmRNSHolding(s) in Company
1st May 20197:00 amRNSTotal Voting Rights
30th Apr 201912:30 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSAnnual Report
18th Apr 20193:05 pmRNSIssue of Shares
12th Apr 201910:45 amRNSCorrection - Issue of Shares
9th Apr 20197:00 amRNSIssue of Shares
2nd Apr 201910:55 amRNSDirector/PDMR Shareholding
1st Apr 20194:40 pmRNSIssue of Shares
27th Mar 201912:25 pmRNSDirector/PDMR Shareholding
25th Mar 20192:30 pmRNSCorrection - Dividend payment schedule
25th Mar 20197:00 amRNSUnaudited Preliminary Results
1st Mar 20192:15 pmRNSTotal Voting Rights
22nd Feb 20193:55 pmRNSIssue of Shares
18th Feb 20197:00 amRNSHolding(s) in Company
12th Feb 20197:00 amRNSPre-close Trading Update
1st Feb 20197:00 amRNSTotal Voting Rights
23rd Jan 20194:50 pmRNSReplacement: Issue of Shares
23rd Jan 20193:25 pmRNSIssue of Shares
14th Jan 20193:35 pmRNSIssue of Shares
3rd Jan 20192:55 pmRNSIssue of Shares
2nd Jan 201911:40 amRNSDirectorate Change
2nd Jan 201911:40 amRNSCompletion of the disposal of the AdIntel division
2nd Jan 20197:00 amRNSTotal Voting Rights
14th Dec 20187:00 amRNSDirectorate Change
5th Dec 20181:45 pmRNSIssue of Shares
22nd Nov 20187:00 amRNSTrading Update
22nd Nov 20187:00 amRNSStatement re CMA final clearance notification
1st Nov 20187:00 amRNSTotal Voting Rights
24th Oct 20182:40 pmRNSIssue of Shares
23rd Oct 20182:05 pmRNSHolding(s) in Company
18th Oct 20184:06 pmRNSIssue of Shares
15th Oct 20187:00 amRNSIssue of Shares
11th Oct 20187:10 amRNSStatement re CMA Provisional Findings
10th Oct 201812:15 pmRNSDirectorate Change
4th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSTotal Voting Rights
27th Sep 20189:10 amRNSIssue of Shares
25th Sep 20187:00 amRNSDirectorate Change
25th Sep 20187:00 amRNSInterim Results
3rd Aug 20188:51 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
27th Jul 20188:59 amRNSHolding(s) in Company
27th Jul 20188:55 amRNSHolding(s) in Company
27th Jul 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jul 20187:00 amRNSInterim Trading Update
20th Jul 20185:00 pmRNSHolding(s) in Company
11th Jul 20183:05 pmRNSAward of options
6th Jul 20183:00 pmRNSIssue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.